VERTEX PHARMACEUTICALS

vertex-pharmaceuticals-logo

Vertex Pharmaceuticals is a biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases. The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. Vertex's product pipeline is focused on viral diseases, cystic fibrosis, inflammation, autoimmune diseases, cancer, and pain.
#SimilarOrganizations #People #Financial #Event #Website #More

VERTEX PHARMACEUTICALS

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
1989-01-01

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.vrtx.com

Total Employee:
1001+

Status:
Active

Contact:
617-341-6100

Email Addresses:
[email protected]

Total Funding:
656.2 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Font Awesome Domain Not Resolving Mobile Non Scaleable Content Nginx


Similar Organizations

cmtx-biotech-logo

CMTx Biotech

CMTx Biotech focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients.

eli-lilly-logo

Eli Lilly

Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.

glycobiochem-logo

GlycoBioChem

GlycoBioChem is focused on discovery and development of novel small-molecules for the purposes of research and treatment of human diseases.

gt-biopharma-logo

GT Biopharma

GT Biopharma specializes in the research and development of therapeutic products used primarily for the treatment of cancer.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

not_available_image

Signal Pharma Ltd.

Signal Pharma Ltd. focus on the discovery and preclinical development of drugs for the treatment of diseases.

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.


Current Advisors List

not_available_image

Dennis Winger Member of the Board of Directors @ Vertex Pharmaceuticals
Board_member

not_available_image

Alan Garber Board Member @ Vertex Pharmaceuticals
Board_member

h-daniel-perez_image

H. Daniel Perez Advisory Board, Neurodegeneration @ Vertex Pharmaceuticals
Advisor
2010-01-01

matthew-emmens_image

Matthew Emmens Chairman of the Board of Director @ Vertex Pharmaceuticals
Board_member

jeffrey-leiden_image

Jeffrey Leiden Chairman of the Board of Directors @ Vertex Pharmaceuticals
Board_member
2009-01-01

lloyd-carney_image

Lloyd Carney Board Member @ Vertex Pharmaceuticals
Board_member
2019-02-01

yuchun-lee_image

Yuchun Lee Member of the Board of Directors @ Vertex Pharmaceuticals
Board_member
2012-09-01

elaine-ullian_image

Elaine Ullian Member of the Board of Directors @ Vertex Pharmaceuticals
Board_member
1997-01-01

Current Employees Featured

reshma-kewalramani_image

Reshma Kewalramani
Reshma Kewalramani President and Chief Executive Officer @ Vertex Pharmaceuticals
President and Chief Executive Officer
2020-04-01

ian-smith_image

Ian Smith
Ian Smith Executive Vice President & CFO @ Vertex Pharmaceuticals
Executive Vice President & CFO

kimberly-white_image

Kimberly White
Kimberly White Senior Vice President and Chief Communications Officer @ Vertex Pharmaceuticals
Senior Vice President and Chief Communications Officer

paul-negulescu_image

Paul Negulescu
Paul Negulescu Vice President @ Vertex Pharmaceuticals
Vice President
2001-01-01

michael-parini_image

Michael Parini
Michael Parini Executive Vice President & Chief Legal and Administrative Officer @ Vertex Pharmaceuticals
Executive Vice President & Chief Legal and Administrative Officer
2016-01-01

ludovic-fenaux_image

Ludovic Fenaux
Ludovic Fenaux Senior Vice President, International Commercial Operations @ Vertex Pharmaceuticals
Senior Vice President, International Commercial Operations

megan-krench_image

Megan Krench
Megan Krench Director of BD - External Innovation @ Vertex Pharmaceuticals
Director of BD - External Innovation
2020-02-01

brian-goldman_image

Brian Goldman
Brian Goldman Research Fellow @ Vertex Pharmaceuticals
Research Fellow

soma-ray_image

Soma Ray
Soma Ray Senior Director, Head of Clinical Biomarkers @ Vertex Pharmaceuticals
Senior Director, Head of Clinical Biomarkers

mark-hollison_image

Mark Hollison
Mark Hollison Procurement and Strategic Sourcing Director @ Vertex Pharmaceuticals
Procurement and Strategic Sourcing Director

Founder


joshua-boger_image

Joshua Boger

Stock Details


Company's stock symbol is NASDAQ:VRTX

Acquisitions List

Date Company Article Price
2022-07-11 ViaCyte ViaCyte acquired by Vertex Pharmaceuticals 320 M USD
2022-03-07 Vectrus Vectrus acquired by Vertex Pharmaceuticals 2.1 B USD
2019-09-03 Semma Therapeutics Semma Therapeutics acquired by Vertex Pharmaceuticals 950 M USD
2019-06-06 Exonics Therapeutics Exonics Therapeutics acquired by Vertex Pharmaceuticals 245 M USD
2001-04-30 Aurora Biosciences Corporation Aurora Biosciences Corporation acquired by Vertex Pharmaceuticals N/A

Investors List

j-p-morgan-securities-inc_image

J.P. Morgan Securities Inc.

J.P. Morgan Securities Inc. investment in Post-IPO Equity - Vertex Pharmaceuticals

bank-of-america-merrill-lynch_image

Bank of America Merrill Lynch

Bank of America Merrill Lynch investment in Post-IPO Equity - Vertex Pharmaceuticals

morgan-stanley_image

Morgan Stanley

Morgan Stanley investment in Post-IPO Equity - Vertex Pharmaceuticals

goldman-sachs_image

Goldman Sachs

Goldman Sachs investment in Post-IPO Equity - Vertex Pharmaceuticals

janssen-pharmaceuticals_image

Janssen Belgium

Janssen Belgium investment in Post-IPO Equity - Vertex Pharmaceuticals

norwest-venture-partners_image

Norwest Venture Partners

Norwest Venture Partners investment in Venture Round - Vertex Pharmaceuticals

j-h--whitney---co_image

J.H. Whitney & Co

J.H. Whitney & Co investment in Venture Round - Vertex Pharmaceuticals

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Venture Round - Vertex Pharmaceuticals

greylock_image

Greylock

Greylock investment in Venture Round - Vertex Pharmaceuticals

Investments List

Date Company Article Money raised
2021-11-09 Arbor Biotechnologies Vertex Pharmaceuticals investment in Series B - Arbor Biotechnologies 215 M USD
2020-03-12 Kymera Therapeutics Vertex Pharmaceuticals investment in Series C - Kymera Therapeutics 102 M USD
2018-12-09 Genomics Vertex Pharmaceuticals investment in Series B - Genomics 8 M EUR
2018-08-30 Genomics Vertex Pharmaceuticals investment in Series B - Genomics 25 M GBP
2015-04-30 CRISPR Therapeutics Vertex Pharmaceuticals investment in Series B - CRISPR Therapeutics 29 M USD

Newest Events participated

oncology-strategy-meeting-europe-2018_event_image Participated in Oncology Strategy Meeting Europe 2018 on 2018-05-22 as speaker

forbes-under-30-summit-2016_event_image Participated in Forbes Under 30 Summit 2016 on 2016-10-16 as sponsor

Key Employee Changes

Date New article
2021-08-04 Vertex Appoints Stuart A. Arbuckle as Chief Operating Officer

Official Site Inspections

http://www.vrtx.com Semrush global rank: 394.34 K Semrush visits lastest month: 141.96 K

  • Host name: 45.60.6.246
  • IP address: 45.60.6.246
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Vertex Pharmaceuticals" on Search Engine

dfkcompany.com © 2022. All rights reserved